Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis

A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.

Detalles Bibliográficos
Autores principales: Zinn, Daniel J, Eckstein, Olive, Olsen, Mary L, Allen, Carl E, McClain, Kenneth L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289025/
https://www.ncbi.nlm.nih.gov/pubmed/32529194
http://dx.doi.org/10.35248/2684-124X.19.4.152
Descripción
Sumario:A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.

Ejemplares similares